OCT 31, 2023
Executive Summary.
After three years of drug manufacturers and regulatory agencies insisting the COVID shots were safe, study findings by independent scientists now show that certain mod-mRNA shots may meet or exceed regulatory standards for “adulteration” with DNA fragments. In the case of the Pfizer/BioNTech product, these fragments appear to include DNA of a particular sequence (SV40 origin-enhancer-promoter) which is biologically active in animal cells. The presence of SV40-derived DNA fragments was not fully disclosed by the manufacturers to regulatory authorities.
This lack of transparency raises serious questions about how these fragments and specific DNA sequences escaped regulatory consideration, and why the presence and risks of significant amounts of SV40- and bacterial-derived small DNA fragments were not discussed by the manufacturers in documents submitted to regulators. The study’s findings have been replicated by other scientists prompting several international medical organizations to call for the immediate recall of all COVID shots.
To be clear, these studies have not found either full-length SV40 DNA, SV40 virus, or the cancer-associated SV40 “Large T antigen” sequences among the contaminants.
FDA, the European Medicines Agency (EMA) and Health Canada assert that there are no risks associated with this DNA fragment adulteration, willfully overlooking the decades-long rich body of peer reviewed literature documenting that both short RNA fragments and DNA fragments (oligonucleotides) can be used to regulate gene expression, and DNA fragments can insert and recombine with genomic DNA in cells, embryos, and tissues. In a wide range of experimental models, insertion and recombination of foreign DNA is associated with both cancer and birth defects.
FDA, EMA and Health Canada also overlook that the self-assembling lipid nanoparticle technology employed to deliver spike-coding mod-mRNA is indiscriminate, and will self-assemble around mod-mRNA, short RNA fragments, and short DNA fragments, efficiently delivering all of these molecules to the cells and tissues of those patients who accept (or are enticed, compelled or coerced to accept) these products. Transfected tissues throughout the body will include ovarian tissue in female patients of all ages, based on the Pfizer non-clinical study data disclosed in their initial common technical document submission.
(Continue reading at this link, no update to paid subscription is required.)
